Ironwood Pharmaceuticals, Inc. (IRWD)
3.50
-0.12
(-3.31%)
USD |
NASDAQ |
Oct 30, 16:00
3.49
-0.01
(-0.29%)
After-Hours: 20:00
Ironwood Pharmaceuticals Cash from Investing (Quarterly) : 0.00 for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.001M |
| September 30, 2025 | -0.002M |
| June 30, 2025 | -0.002M |
| March 31, 2025 | -0.031M |
| December 31, 2024 | 0.00 |
| September 30, 2024 | -0.016M |
| June 30, 2024 | -0.058M |
| March 31, 2024 | -0.068M |
| December 31, 2023 | -4.188M |
| September 30, 2023 | -22.62M |
| June 30, 2023 | -999.49M |
| March 31, 2023 | -0.013M |
| December 31, 2022 | 0.027M |
| September 30, 2022 | -0.066M |
| June 30, 2022 | -0.088M |
| March 31, 2022 | -0.009M |
| December 31, 2021 | -0.128M |
| September 30, 2021 | -0.137M |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | -0.028M |
| September 30, 2020 | 0.00 |
| June 30, 2020 | -0.376M |
| Date | Value |
|---|---|
| March 31, 2020 | -1.438M |
| December 31, 2019 | -2.661M |
| September 30, 2019 | -3.077M |
| June 30, 2019 | -2.429M |
| March 31, 2019 | -2.977M |
| December 31, 2018 | 17.49M |
| September 30, 2018 | 14.28M |
| June 30, 2018 | 12.44M |
| March 31, 2018 | 44.65M |
| December 31, 2017 | -33.85M |
| September 30, 2017 | 26.66M |
| June 30, 2017 | 70.60M |
| March 31, 2017 | 88.06M |
| December 31, 2016 | -115.42M |
| September 30, 2016 | -90.36M |
| June 30, 2016 | 4.763M |
| March 31, 2016 | 23.35M |
| December 31, 2015 | 34.91M |
| September 30, 2015 | 21.83M |
| June 30, 2015 | -85.66M |
| March 31, 2015 | 19.76M |
| December 31, 2014 | 38.31M |
| September 30, 2014 | -7.883M |
| June 30, 2014 | -80.52M |
| March 31, 2014 | -6.472M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| AbbVie, Inc. | -- |
| Xencor, Inc. | 85.12M |
| Viking Therapeutics, Inc. | 92.52M |
| IDEAYA Biosciences, Inc. | -155.93M |
| BioMarin Pharmaceutical, Inc. | -5.102B |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 58.28M |
| Cash from Financing (Quarterly) | -199.70M |
| Free Cash Flow | 185.55M |
| Free Cash Flow Per Share (Quarterly) | 0.3486 |
| Free Cash Flow to Equity (Quarterly) | 258.77M |
| Free Cash Flow to Firm (Quarterly) | 63.29M |
| Free Cash Flow Yield | 31.46% |